Conference Coverage
Conference Coverage
In COVID-19 patients, risk of bleeding rivals risk of thromboembolism
Conference Coverage
"Lipid paradox” seen in nonobese RA patients with low LDL
Conference Coverage
Disabling stroke reduced with ticagrelor after minor stroke, TIA
“This new information on disabling stroke underlines the importance of getting patients on dual antiplatelet therapy quickly after a TIA or mild...
Conference Coverage
Cost is the main hurdle to broad use of caplacizumab for TTP
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said...
Conference Coverage
VTE prophylaxis is feasible, effective in some high-risk cancer patients
Conference Coverage
Obesity phenotyping matches patients with more effective interventions
A prospective, randomized study suggests obesity phenotyping can guide selection of more effective, tailored weight-loss drug regimens.
Conference Coverage
Metformin improves most outcomes for T2D during pregnancy
But the drug was associated with an increased risk of small-for-gestational-age babies.
Conference Coverage
Blood pressure treatment reduces bleeding in ICH
The management of blood pressure in ICH is complex. Timing, type of drug, and type of patient must be considered.
Conference Coverage
Finerenone’s heart benefits hold up in T2D patients without CVD
In the FIDELIO-DKD trial, cardiovascular benefits from a nonsteroidal mineralocorticoid antagonist held, regardless of CVD history, in T2D...
Conference Coverage
Potential new option: 1-month DAPT post DES, then aspirin alone
The One-Month DAPT trial swapped aspirin monotherapy for prolonged P2Y12 inhibition.
Conference Coverage
Marijuana use tied to repeat MI, stroke after percutaneous coronary intervention
“It is absolutely critical” that cardiologists and general providers screen patients for marijuana use, “either at the time of their MI or ideally...